Get the latest news in Felixvet’s ongoing commitment to creating the country’s most compassionate, cost-effective companion animal bioequivalent pharmaceuticals.
Get the latest news in Felixvet’s ongoing commitment to creating the country’s most compassionate, cost-effective companion animal bioequivalent pharmaceuticals.
Felixvet has secured FDA approval for Clindamycin Hydrochloride Tablets to treat bacterial infections in dogs. Learn more about this reliable treatment option!
Read Article
Felixvet announces the commercial availability of Dexmedetomidine Hydrochloride Sterile Injectable Solution 0.5 mg/mL, an FDA-approved sedative, analgesic, and...
Read Article
Felixvet announces the commercial availability of Atipamezole Hydrochloride Injection, a sterile injectable solution indicated for the reversal of...
Read Article
Felixvet Inc. today announced the commercial availability of Maropitant Citrate Chewable Tablets, an FDA-approved antiemetic indicated for the...
Read Article
Felixvet has secured FDA approval for Clindamycin Hydrochloride Tablets to treat bacterial infections in dogs. Learn more about...
Read Article
Felixvet has secured FDA approval for Clindamycin Hydrochloride Tablets to treat bacterial infections in dogs. Learn more about...
Read Article
Felixvet earns FDA approval for Cefpodoxime Proxetil Tablets, an antimicrobial indicated for the treatment of skin infections in...
Read Article